ArticleIntegrative cancer therapies

Safety Evaluation of SH003 and Docetaxel Combination in Patients With Breast and Lung Cancer: A Multi-Center, Open-Label, Dose Escalation Phase I Clinical Trial.

Chunhoo Cheon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.